🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to assess the safety and antitumor activity of ABL103 plus pe...
Status
Recruiting
Location
UH Cleveland Medical Center
Start Date
2025-08-06
Trial ID
NCT07158918
Treatments Being Tested
This is a prospective two-stage single arm phase II study to be conducted i...
Status
Completed
Location
AOU Modena
Start Date
2018-12-12
Trial ID
NCT03732391
Treatments Being Tested
The main purpose of this study is to assess the safety, tolerability and an...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2017-11-29
Trial ID
NCT03087760
Treatments Being Tested
This is an open-label, non-randomized, Phase I, dose escalation/dose expans...
Status
Completed
Location
City of Hope
Start Date
2023-06-20
Trial ID
NCT05826275
Treatments Being Tested
The study is a 2-part study of Tinodasertib alone or in combination with Pe...
Status
Recruiting
Location
Chris O'Brien Lifehouse
Start Date
2023-04-14
Trial ID
NCT05462236
Treatments Being Tested
This is an open label trial of Anti PD1/MD-3475, Pomalidomide and dexametha...
Status
Terminated
Location
Greenebaum Cancer Center at University of Maryland Medical Center
Start Date
2014-12-30
Trial ID
NCT02289222
Treatments Being Tested
This research study is studying an investigational combination of drugs as ...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2018-05-01
Trial ID
NCT03239145
Treatments Being Tested
This first time in human (FTIH) open-label, dose escalation study will asse...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-30
Trial ID
NCT02783300
Treatments Being Tested
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
This is a multicenter screening protocol designed to identify patients with...
Status
Terminated
Location
Southern Cancer Center
Start Date
2021-01-19
Trial ID
NCT04698681